Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles matching "Pulmonary Arterial Hypertension"

Clinical trialRSSYesterday

Adding LAM-001 inhaled therapy leads to broad benefits for PH

Researchers tested a new inhaled medicine called LAM-001 on patients with two types of lung disease: pulmonary hypertension combined with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH). All patients who finished the small early-stage trial showed significant improvement in their symptoms. The results are encouraging enough that the company plans to continue testing this medicine.

WHY IT MATTERSIf LAM-001 proves effective in larger trials, it could offer a new treatment option for PH-ILD patients, a condition with limited approved therapies that causes progressive breathing difficulty and high pressure in lung blood vessels.
👁 Watch this spacepulmonary hypertension with interstitial lung diseasepulmonary arterial hypertension
Clinical trialRSSApr 22

First patient enrolled in Phase 3 trial of PAH treatment IKT-001

A new clinical trial has started testing a drug called IKT-001 in people with pulmonary arterial hypertension (PAH), a rare condition where blood vessels in the lungs become narrowed and make it hard for the heart to pump blood. This is a large Phase 3 trial, which is a late-stage test that happens before a drug might be approved. Nearly 500 adults will participate to see if this drug works better than current treatments.

WHY IT MATTERSIf you have PAH and are already on stable treatment, you may be eligible to join the IMPROVE-PAH trial and potentially access IKT-001 before it becomes widely available.
→ You can act on thispulmonary arterial hypertension

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases